These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Clinical investigation of carbohydrate antigen CA-50]. Ishii M, Abe O, Okura H, Okazaki N, Kawai T, Saito Y, Sawabu N, Takamizawa Y, Takeuchi T, Niitani H. Gan To Kagaku Ryoho; 1987 Aug; 14(8):2548-55. PubMed ID: 3304170 [Abstract] [Full Text] [Related]
4. Analysis of CA-125 levels in the sera of patients with non-ovarian carcinomas and non-malignant diseases. Marechal F, Berthiot G, Kritly T, Legrand MG, Deltour G, Cattan A. Anticancer Res; 1989 Aug; 9(3):593-8. PubMed ID: 2764505 [Abstract] [Full Text] [Related]
6. Comparison of three immunoassays for CA 19-9. Hotakainen K, Tanner P, Alfthan H, Haglund C, Stenman UH. Clin Chim Acta; 2009 Feb; 400(1-2):123-7. PubMed ID: 19038241 [Abstract] [Full Text] [Related]
7. Comparison of four 'second generation' immunoassay systems to determine CA 125 in serum by using a graphical approach to method comparison analysis. Koper NP, Thomas CM, Massuger LF, Segers MF, Kiemeney LA, Verbeek AL. Eur J Clin Chem Clin Biochem; 1997 Aug; 35(8):617-23. PubMed ID: 9298352 [Abstract] [Full Text] [Related]
10. [CA 19-9 enzyme immunoassay]. Ota H, Odani H, Watanabe H, Satomura Y, Takemori Y, Okai T, Sawabu N, Mai M, Hattori N, Hashimoto T. Gan No Rinsho; 1986 Aug; 32(9):993-7. PubMed ID: 3528560 [Abstract] [Full Text] [Related]
13. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen]. Olsson NO, Crimet-Montange D, Martin F. Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449 [Abstract] [Full Text] [Related]
14. [Serum determination of CA 19-9 in patients with digestive cancers and its diagnostic evaluation]. Arakawa Y, Kobayashi H, Ozaki T, Ariga H, Matsuo Y, Honda T, Arai T, Kurosu Y, Morita K, Konuma H. Gan To Kagaku Ryoho; 1984 Apr; 11(4):917-25. PubMed ID: 6586110 [Abstract] [Full Text] [Related]
15. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies]. Gang Y, Adachi I, Ohkura H, Yamamoto H, Mizuguchi Y, Abe K. Gan To Kagaku Ryoho; 1985 Dec; 12(12):2379-86. PubMed ID: 3865634 [Abstract] [Full Text] [Related]
16. [Evaluation of CA 15-3 radioimmunoassay]. Takemori Y, Odani H, Watanabe H, Ohta H, Satomura Y, Okai T, Sawabu N, Mai M, Hattori N, Hashimoto T. Gan To Kagaku Ryoho; 1987 Jan; 14(1):114-8. PubMed ID: 3467654 [Abstract] [Full Text] [Related]
17. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer. Koelbl H, Schieder K, Neunteufel W, Bieglmayer C. Neoplasma; 1989 Jan; 36(4):473-8. PubMed ID: 2770933 [Abstract] [Full Text] [Related]
18. A multicentre evaluation of tumour marker determinations using the automatic Enzymun-Test Systems ES 300 and ES 600/700. van Dalen A, Kessler AC. Eur J Clin Chem Clin Biochem; 1996 Apr; 34(4):377-84. PubMed ID: 8704058 [Abstract] [Full Text] [Related]